##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
 FORM 10-K/A AMENDMENT No. 1
FOR ANNUAL AND TRANSACTION REPORTS PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
(MARK ONE)þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM __________ TO __________ COMMISSION FILE NUMBER: 001-31375 WINDROSE MEDICAL PROPERTIES TRUST (Exact name of registrant as specified in its charter)
 MARYLAND
    
    35-216691(State or other jurisdiction of
    
    (I.R.S. Employerincorporation or organization)
    
    Identification No.)
 3502 WOODVIEW TRACE, SUITE 210,
INDIANAPOLIS, IN 46268
(Address of principal executive offices) (317) 860-8180
(Registrants telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of Each Class
    
    Name of Each Exchange on Which RegisteredCommon Shares of Beneficial Interest, par value of $0.01 per share
    
    New York Stock Exchange
 Securities registered pursuant to Section 12(g) or the Act: Title of Each Class: None: Indicate by check mark whether the Registrant (i) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the Registrant was required to file such reports), and (ii) has been
subject to such filing requirements for the past 90 days. Yes:þ      Noo Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is
not contained herein, and will not be contained, to the best of Registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K.o Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act
Rule 12b-2). Yes:þ      Noo Aggregate market value of the voting stock held by non-affiliates of the Registrant: $105,550,710
as of June 30, 2004 and $163,925,175 as of February 28, 2005. As of February 28, 2005, there were 11,642,413 common shares outstanding. Documents incorporated by reference: Portions of the Registrants definitive Proxy Statement to be filed with the Securities and
Exchange Commission no later than 120 days after the Registrants fiscal year ended December 31,
2004, and to be delivered to shareholders in connection with the 2005 Annual Meeting of
Shareholders to be held on April 26, 2005, are incorporated by reference into Part III.




---



TABLE OF CONTENTS  EXPLANATORY NOTESIGNATURESSIGNATURESEX-21.01  LIST OF SUBSIDIARIES    Table of Contents  
 EXPLANATORY NOTE On March 14, 2005, Windrose Medical Properties Trust filed its Annual Report on Form 10-K for
the fiscal year ended December 31, 2004. This Amendment No. 1 has been filed to correct the
inadvertent error on page 39, under the caption Signature by changing the dates of the conformed
signatures on page 39 from March 14, 2004 to March 14, 2005. This Amendment No. 1 has also been
filed to correct an inadvertent omission by updating a previously filed exhibit, Exhibit 21.01, to
include all new subsidiaries of the Company since this exhibit was last filed. As a result, the
exhibit index on page 37, under Part IV (3) has also been amended to state that Exhibit 21.01 is
filed herewith. We have not made any other changes. The corrected pages follow. 
 SIGNATURES Pursuant to the requirements of the Section 13 or 15(d) of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized on the 15th day of March, 2005. WINDROSE MEDICAL PROPERTIES TRUSTBy:
    /s/ C. DOUGLAS HANSONC. Douglas HansonChief Financial Officer




---



##### Table of Contents



ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (a) THE FOLLOWING DOCUMENTS ARE FILED AS PART OF THIS FORM 10-K: 1. CONSOLIDATED FINANCIAL STATEMENTS PageIndex to Financial statements
    
    F-1Reports of Independent Registered Public Accounting Firm
    
    F-2Consolidated Statements of Operations, Years Ended December 31, 2004,
2003, 2002, and the period January 1, 2002 through August 15, 2002
and the period August 16, 2002 through December 31, 2002
    
    F-3Consolidated Balance Sheets, December 31, 2004 and 2003
    
    F-4Consolidated Statements of Cash Flows, Years Ended December 31, 2004,
2003 and 2002
    
    F-5Consolidated Statements of Shareholders Equity (Deficit), Years
Ended December 31, 2004, 2003 and 2002
    
    F-6Notes to Consolidated Financial Statements
    
    F-7
 2. CONSOLIDATED FINANCIAL STATEMENT SCHEDULES Schedule III  Real Estate and Accumulated Depreciation 3. EXHIBITS The following exhibits are filed with this Form 10-K or incorporated herein by reference to the
listed documents previously filed with the Securities and Exchange Commission. EXHIBITNUMBER
    
    DESCRIPTION3.01
    
    
    Registrants Articles of Incorporation.*3.02
    
    
    Registrants Bylaws.*4.01
    
    
    Form of Common Share Certificate.*4.02
    
    
    Form of Warrant.**10.01
    
    
    Amended and Restated Agreement of Limited Partnership of Windrose
Medical Properties, L.P.*10.02
    
    
    Windrose Medical Properties Trust 2002 Stock Incentive Plan.*10.03
    
    
    Overhead Sharing Agreement between Windrose Medical Properties,
L.P. and Klipsch Audio, Inc.*10.05
    
    
    Promissory Note dated August 2, 1999 from Park Medical Associates
General Partnership to General Electric Capital Corporation.*10.06
    
    
    Loan Agreement dated August 2, 1999 between General Electric
Capital Corporation and Park Medical Associates General
Partnership.*10.07
    
    
    Deed of Trust, Assignment of Leases and Rents, Security Agreement
and Fixture Filing from Park Medical Associates General
Partnership to Charles T. Marshall (Trustee) for the benefit of
General Electric Capital Corporation.*10.08
    
    
    Form of Change in Control Severance Agreement between Windrose
Medical Properties, L.P. and Fred S. Klipsch.*10.09
    
    
    Form of Change in Control Severance Agreement between Windrose
Medical Properties, L.P. and Frederick L. Farrar.*10.10
    
    
    Employment Agreement between Windrose Medical Properties Trust,
Windrose Medical Properties, L.P. and Fred S. Klipsch, dated
February 21, 2005.*****10.11
    
    
    Employment Agreement between Windrose Medical Properties Trust,
Windrose Medical Properties, L.P. and Frederick L. Farrar, dated
February 21, 2005.*****10.12
    
    
    Subordinated Promissory Note dated September 28, 2001 from
Windrose International L.L.C. to Fred Klipsch.*
 36




---



##### Table of Contents



EXHIBITNUMBER
    
    DESCRIPTION10.13
    
    
    Subordinated Promissory Note dated May 11, 2002 from Windrose
International, L.L.C. to Klipsch Audio, Inc.*10.14
    
    
    Promissory Note dated May 1, 1999 from Hospital Affiliates
Development Corporation to Robin P. Barksdale.*10.15
    
    
    Promissory Note dated May 1, 1999 from Hospital Affiliates
Development Corporation to Frederick L. Farrar.*10.16
    
    
    Promissory Note dated May 1, 1999 from Hospital Affiliates
Development Corporation to Fred S. Klipsch.*10.17
    
    
    Promissory Note dated May 1, 1999 from Hospital Affiliates
Development Corporation to Athena Development.*10.18
    
    
    Subordinated Promissory Note dated May 11, 2002 from Windrose
International, L.L.C. to Charles Lanham.*10.19
    
    
    Promissory Note payable by Alliance Design Group to Hospital
Affiliates Development Corporation.*10.20
    
    
    Secured Revolving Credit Agreement, dated September 27, 2002, by
and between Windrose Medical Properties, L.P. and The Huntington
National Bank.*10.21
    
    
    Credit Note, dated September 27, 2002, from Windrose Medical
Properties, L.P. to The Huntington National Bank.*10.22
    
    
    Secured Construction Loan Facility with Huntington National Bank,
dated as of September 10, 2004.*****10.23
    
    
    Secured Construction Loan Facility with Huntington National Bank,
dated as of December 3, 2004.****21.01
    
    
    List of Subsidiaries of the Registrant.****23.01
    
    
    Consent of KPMG LLP.****31.01
    
    
    Certification of Chief Executive Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.****31.02
    
    
    Certification of Chief Financial Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.****31.03
    
    
    Certification of Chief Operating Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.****32.01
    
    
    Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002.****32.02
    
    
    Certification of Chief Financial Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002.****32.03
    
    
    Certification of Chief Operating Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to section 906 of the
Sarbanes-Oxley Act of 2002.****
   *
    
    Previously filed as an exhibit to the Companys
Registration Statement on Form S-11, as amended,
Registration No. 333-89186, and incorporated by
reference herein.**
    
    Previously filed as an exhibit to the Companys
Registration Statement on Form S-3, Registration No.
333-108659, and incorporated by reference herein.***
    
    Previously filed as an exhibit to the Companys
Registration Statement on Form S-11, as amended,
Registration No. 333-110612, and incorporated by
reference herein.****
    
    Filed herewith.*****
    
    Previously filed as an exhibit to the Companys
Current Report on Form 8-K, dated February 22, 2005
and incorporated by reference herein.******
    
    Previously filed as an exhibit to the Companys
Quarterly Report on Form 10-Q for the quarter ended
September 30, 2004, and incorporated by reference
herein. 37




---



##### Table of Contents



(b) EXHIBITS The exhibits required to be filed with this Form 10-K pursuant to Item 601 of regulation S-K are
listed under Exhibits in Part IV, Item 15(a)(3) of this Form 10-K, and are incorporated herein
by reference. (c) FINANCIAL STATEMENT SCHEDULE The Financial Statement Schedule required to be filed with this Form 10-K is listed under
Consolidated Financial Statement Schedules in Part IV, Item 15(a)(2) of this Form 10-K, and is
incorporated herein by reference. 38




---



##### Table of Contents



SIGNATURES PURSUANT TO THE REQUIREMENTS OF SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, THE
REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THEREUNTO
DULY AUTHORIZED. WINDROSE MEDICAL PROPERTIES
TRUST (Registrant)Date: March 14, 2005
    By:
    /s/ FRED S. KLIPSCHFRED S. KLIPSCHCHAIRMAN, CHIEF EXECUTIVE OFFICER, AND TRUSTEE
(PRINCIPAL EXECUTIVE OFFICER) By:
    /s/ C. DOUGLAS HANSONC. DOUGLAS HANSONVICE PRESIDENT AND CHIEF FINANCIAL OFFICER
(PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER) PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THIS REPORT HAS BEEN SIGNED
BELOW BY THE FOLLOWING PERSONS ON BEHALF OF THE REGISTRANT AND IN THE CAPACITIES AND ON THE DATES
INDICATED. SIGNATURE
    
    TITLE
    
    DATE/s/ FRED S. KLIPSCH

FRED S. KLIPSCH
    
    Chairman, Chief Executive Officer, and Trustee
(Principal Executive Officer)
    
    March 14, 2005/s/ FREDERICK L. FARRAR

FREDERICK L. FARRAR
    
    President, Chief Operating Officer and Treasurer
    
    March 14, 2005/s/ BRYAN MILLS

BRYAN MILLS
    
    Trustee
    
    March 14, 2005/s/ STEPHEN GOLDSMITH

STEPHEN GOLDSMITH
    
    Trustee
    
    March 14, 2005/s/ BRUCE M. JACOBSON

BRUCE M. JACOBSON
    
    Trustee
    
    March 14, 2005/s/ JEAN L. WOJTOWICZ

JEAN L. WOJTOWICZ
    
    Trustee
    
    March 14, 2005/s/ DAVID L. MARAMAN

DAVID L. MARAMAN
    
    Trustee
    
    March 14, 2005/s/ DARRELL E. ZINK, JR.

DARRELL E. ZINK, JR.
    
    Trustee
    
    March 14, 2005
 39